Roome Mishra
Businessman and Tesla Motors CEO Elon Musk supports Britain’s official ban on Children’s Puberty Blockers on an X post. A high court judge has ruled that the ban on prescribing puberty blockers to children with gender dysphoria in England, Scotland, and Wales is lawful.
Elon Musk’s trans daughter had also allegedly taken puberty blockers. In a controversial statement, Musk has claimed he was ‘tricked’ into allowing his trans child to use the said blockers.
Elon Musk supports ban of puberty blockers
Elon Musk is a staunch Trump supporter. This has to do with his beliefs that are, according to him, not “woke”. Recently Elon shared a post on X (formerly known as Twitter) that he supports the Britain Government’s Ban on Children’s Puberty Blockers.
Musk’s post read: “Britain has rightfully banned puberty blockers for children for the immense and permanent harm they do.”
This comes days after Elon claiming that his estranged trans daughter took Puberty Blockers as well.
The billionaire alleged he was “tricked” into signing documents that permitted Vivian to receive puberty blockers. Using male pronouns, Musk claimed his “son” had been figuratively “killed” by “the woke mind virus.”
Referring to her with male pronouns, Musk said his “son” had been (figuratively) “killed” by “the woke mind virus”. Vivian has now shot back, saying she had “dis
owned him, not the other way around”. In 2022, she requested to change her name from Xavier to Vivian and to take her mother Justine Wilson’s surname.
“I no longer want to be related to my biological father in any way, shape or form,” Vivian had reportedly said.
Britain bans Puberty Blockers
On May 29, the Conservative government issued an emergency order temporarily banning the provision of puberty blockers based on overseas prescriptions, following Dr. Hilary Cass’s review of gender medicine.
The review highlighted insufficient evidence regarding the benefits and risks of puberty blockers, and the legislation aimed to ensure they could only be accessed through authorized clinical trials.
in a judgment handed down on Monday, 29 July, Mrs. Justice Lang said that Atkins had acted in accordance with the law.
The judge wrote: “In my view, it was rational for the first defendant to decide that it was essential to adopt the emergency procedure to avoid serious danger to the health of children and young people who would otherwise be prescribed puberty blockers during that five- to six-month period. Under the emergency procedure, there is no requirement to hold a consultation procedure”
“In my judgment, the Cass review’s findings about the very substantial risks and very narrow benefits associated with the use of puberty blockers, and the recommendation that in future the NHS prescribing of puberty blockers to children and young people should only take place in a clinical trial, and not routinely, amounted to powerful scientific evidence in support of restrictions on the supply of puberty blockers on the grounds that they were potentially harmful.”
GIPHY App Key not set. Please check settings